Drug intelligence / Profile preview

18F-fluorodeprenyl

Lead developer
Bayer
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

18F-fluorodeprenyl (specifically its bis-deuterated version, 18F-fluorodeprenyl-D2 or [18F]F-DED, also known as LNTH-2511) is an investigational fluorine-18-labeled positron emission tomography (PET) radioligand designed to target monoamine oxidase B (MAO-B). MAO-B is an enzyme primarily located on the outer mitochondrial membranes of glial cells and is significantly upregulated in reactive astrocytes during neuroinflammation. By binding selectively to MAO-B, 18F-fluorodeprenyl serves as a diagnostic imaging agent to visualize and quantify reactive astrogliosis in vivo. It is being evaluated as a biomarker for disease activity and progression in neurodegenerative and neuroinflammatory conditions, including Alzheimer's disease, multiple system atrophy (MSA), multiple sclerosis (MS), and autoimmune encephalitis (such as GAD65-antibody and LGI1-antibody autoimmune encephalitis). Originally developed by researchers at the Karolinska Institutet in collaboration with Bayer, the asset was subsequently developed by Life Molecular Imaging, which was acquired by Lantheus in 2025.

Other names
[18F]D2-deprenyl[18F]F-D-Deprenyl[18F]F-DED18F-D2-Deprenyl18F-fluorodeprenyl-D2deuterated fluorodeprenylfluorine-18-labeled L-deprenyl analoguefluorine18-labeled L-deprenyl analoguefluorine 18-labeled L-deprenyl analoguefluorodeprenyl-D2fluorodeprenyl-D-2fluorodeprenyl-D 2
02

Identity

Drug type
Radiopharmaceuticals
Originator
Karolinska Institutet and Bayer HealthCare AG
Modality
Small MoleculesAntibody-Based TherapeuticsAntibody-Radionuclide ConjugatesPositron Emitters
Synonyms and codes
18F-LNTH-2511
03

Pharmacology

Route
Intravenous
04

Development

IndicationHighest phaseStatus
Alzheimer's disease (AD)In developmentActive
atypical parkinsonian syndromesPreclinicalActive
autoimmune encephalitisPreclinicalActive
dysautonomiaPreclinicalActive
multiple sclerosis (MS)PreclinicalActive
multiple system atrophy (MSA)PreclinicalActive

Every indication, with countries and timelines, is in the full profile.

05

Regulatory

MarketStatusYear
United StatesNot approved—
European UnionNot approved—
ChinaNot approved—
JapanNot approved—

Approved indications and other markets are in the full profile.

06

Companies

  • Karolinska Institutet and Bayer HealthCare AGOriginator
  • BayerLead developer
07

Patents & exclusivity

Patents
2

Patent families, expiry dates and exclusivities are in the full profile.

08

Competitive landscape

Drugs on the same target
40
Drugs in the lead indication
29

Lead indication: autoimmune encephalitis

Most advanced in the lead indication

  1. amantadineApproved
  2. flortaucipir f-18Approved
  3. isocarboxazidApproved
  4. linezolidApproved
  5. phenelzineApproved

Beyond the preview

Go deeper on 18F-fluorodeprenyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-fluorodeprenyl.

Work on 18F-fluorodeprenyl? Claim this page to correct or add information. Claim this page

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call